GSA Capital Partners’s Ovid Therapeutics OVID Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $245K | Buy |
742,190
+302,087
| +69% | +$99.7K | 0.02% | 1392 |
|
|
2025
Q1 | $137K | Buy |
440,103
+316,520
| +256% | +$98.5K | 0.01% | 1467 |
|
|
2024
Q4 | $115K | Sell |
123,583
-136,926
| -53% | -$127K | 0.01% | 1502 |
|
|
2024
Q3 | $307K | Buy |
260,509
+141,002
| +118% | +$166K | 0.02% | 1200 |
|
|
2024
Q2 | $92K | Buy |
+119,507
| New | +$92K | 0.01% | 1534 |
|
|
2021
Q2 | – | Sell |
-75,888
| Closed | -$305K | – | 1526 |
|
|
2021
Q1 | $305K | Sell |
75,888
-115,945
| -60% | -$466K | 0.05% | 638 |
|
|
2020
Q4 | $443K | Buy |
191,833
+134,959
| +237% | +$312K | 0.07% | 494 |
|
|
2020
Q3 | $326K | Buy |
+56,874
| New | +$326K | 0.05% | 677 |
|